Then, considering the KEGG pathways “Glioma” (Figure 5a) and “Proteoglycans in cancer” (Figure 5b), we evaluated how many miRNAs of each group (BAD-SPECIFIC and shared with GOOD) were involved, how many genes of the pathways could be modulated by upregulated or downregulated miRNAs, and the significance of the association. Here, BAD is linked to cancer.